Page 1

ResearchAarkstoreEnterprise Companion Diagnostics Partnering Terms & Agreements The Companion Diagnostics Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the companion diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter companion diagnostic partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors companion diagnostics technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases do not. This report contains over 1,000 links to online copies of actual companion diagnostics deals and contract documents as submitted to the Securities Exchange Commission by companies

and their partners. Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal. The initial chapters of this report provide an orientation of companion diagnostic dealmaking and business activities. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in companion diagnostic dealmaking since 2007, including details of average headline, upfront, milestone and royalty terms. Chapter 3 provides a review of the leading companion diagnostic deals since 2007. Deals are listed by headline value, signed by bigpharma, most active bigpharma, and most active of all biopharma companies. Where the deal has an agreement contract published at the SEC a link provides online access to the contract. Chapter 4 provides a comprehensive listing of the top 50 bigpharma companies with a brief summary followed by a comprehensive listing of companion diagnostic deals, as well as contract documents available in the public domain. Where available, each deal title links via Weblink to an online version of the actual contract document, providing easy access to each contract document on demand. For more information please visit link:

Neel Aarkstore Enterprise Phone:08149852585

Biomarker Partnering Terms & Agreements Companion Diagnostics Partnering Terms & Agreements Bioinformatics Partnering Terms & Agreements Personalized Medicine Partnering Terms and Agreements Personalized Medicine Partnering Terms and Agreements Dermatology Partnering Terms and Agreements Cardiovascular Partnering Terms and Agreements Obstretics Partnering 2007-2012 Musculoskeletal Partnering Agreements Oncology Partnering Terms and Agreements Pediatrics Partnering Terms and Agreements Metabolic Partnering Terms and Agreements Immunology Partnering Terms and Agreements Genitourinary Partnering Terms and Agreements Gastrointestinal Partnering Terms and Agreements Dental Partnering Terms and Agreements Central Nervous System Partnering Terms and Agreements Sexual Health Partnering Terms and Agreements Mucositis Partnering 2007-2012

Oral Health Partnering 2007-2012 AIDS Partnering 2007-2012 Allergy Partnering 2007-2012 Systemic Lupus Partnering 2007-2012 Inflammatory Partnering 2007-2012 Gynecology Partnering Terms and Agreements Respiratory Partnering Terms and Agreements Bacterial Partnering Terms and Agreements Viral Partnering Terms and Agreements Anthrax Partnering 2007-2012 E.coli Partnering 2007-2012 MRSA Partnering 2007-2012 Sepsis Partnering 2007-2012 Common Cold Partnering 2007-2012 Hepatitis Partnering 2007-2012 Herper simplex Partnering 2007-2012 HIV Partnering 2007-2012 Influenza Partnering 2007-2012 RSV Partnering 2007-2012 Parasitic Partnering 2007-2012 Fungal Partnering 2007-2012 Tropical Disease Partnering 2007-2012 Dengue Fever Partnering 2007-2012 Malaria Partnering 2007-2012 Renal Failure Partnering 2007-2012 Dialysis Partnering 2007-2012 Genitourinary Symptoms Partnering 2007-2012 Chronic Kidney Disease Partnering 2007-2012 Blood Substitute Partnering 2007-2012 Anemia Partnering 2007-2012 Hemophilia Partnering 2007-2012

ResearchAarkstoreEnterprise Companion Diagnostics Partnering Terms & Agreements